Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Sturchio

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Parkinsonism & Related Disorders|November 21, 2020
Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesAndrea Sturchio, Matteo Gastaldi, Lucia Princiotta Cariddi, et al.
Expert Review of Neurotherapeutics|October 2, 2018
Technology-based assessment of motor and nonmotor phenomena in Parkinson diseaseAristide Merola, Andrea Sturchio, Stephanie Hacker, et al.
Movement Disorders Clinical Practice|September 24, 2025
High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's DiseaseAndrea Sturchio, Wojciech Paslawski, Shervin Khosousi, et al.
Cerebellum (London, England)|January 23, 2020
Impaired Saccade Adaptation in Tremor-Dominant Cervical Dystonia-Evidence for Maladaptive CerebellumAbhimanyu Mahajan, Palak Gupta, Jonathan Jacobs, et al.
Parkinsonism & Related Disorders|May 23, 2022
Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionLuca Marsili, Kevin R Duque, Andrea Sturchio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 27, 2024
Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI CohortsShervin Khosousi, Andrea Sturchio, Ellen Appleton, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2020
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized PotentialCarlo Alberto Artusi, Gabriele Imbalzano, Andrea Sturchio, et al.
Translational Neurodegeneration|June 11, 2024
DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's diseaseEllen Appleton, Shervin Khosousi, Michael Ta, et al.
Neurology. Clinical Practice|September 6, 2021
Biphasic (Subtherapeutic) Levodopa-Induced Respiratory Dysfunction in Parkinson DiseaseVeerle A van de Wetering-van Dongen, Alberto J Espay, Luca Marsili, et al.
Brain Sciences|February 23, 2024
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician's PerspectiveAndrea Sturchio, Emily M Rocha, Marcelo A Kauffman, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Parkinsonism & Related Disorders|November 21, 2020
Levodopa-responsive progressive encephalomyelitis with rigidity and myoclonus associated with glycine receptor antibodiesAndrea Sturchio, Matteo Gastaldi, Lucia Princiotta Cariddi, et al.
Expert Review of Neurotherapeutics|October 2, 2018
Technology-based assessment of motor and nonmotor phenomena in Parkinson diseaseAristide Merola, Andrea Sturchio, Stephanie Hacker, et al.
Movement Disorders Clinical Practice|September 24, 2025
High Cerebrospinal DOPA Decarboxylase Level Predicts Cognitive Decline in Parkinson's DiseaseAndrea Sturchio, Wojciech Paslawski, Shervin Khosousi, et al.
Cerebellum (London, England)|January 23, 2020
Impaired Saccade Adaptation in Tremor-Dominant Cervical Dystonia-Evidence for Maladaptive CerebellumAbhimanyu Mahajan, Palak Gupta, Jonathan Jacobs, et al.
Parkinsonism & Related Disorders|May 23, 2022
Droxidopa reduces postural sway in Parkinson disease patients with orthostatic hypotensionLuca Marsili, Kevin R Duque, Andrea Sturchio, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 27, 2024
Increased CSF DOPA Decarboxylase Correlates with Lower DaT-SPECT Binding: Analyses in Biopark and PPMI CohortsShervin Khosousi, Andrea Sturchio, Ellen Appleton, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 1, 2020
Implementation of Mobile Health Technologies in Clinical Trials of Movement Disorders: Underutilized PotentialCarlo Alberto Artusi, Gabriele Imbalzano, Andrea Sturchio, et al.
Translational Neurodegeneration|June 11, 2024
DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's diseaseEllen Appleton, Shervin Khosousi, Michael Ta, et al.
Neurology. Clinical Practice|September 6, 2021
Biphasic (Subtherapeutic) Levodopa-Induced Respiratory Dysfunction in Parkinson DiseaseVeerle A van de Wetering-van Dongen, Alberto J Espay, Luca Marsili, et al.
Brain Sciences|February 23, 2024
Recalibrating the Why and Whom of Animal Models in Parkinson Disease: A Clinician's PerspectiveAndrea Sturchio, Emily M Rocha, Marcelo A Kauffman, et al.
Pageof 6